INMB

INmune Bio (INMB)

About INmune Bio (INMB)

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.

Details

Daily high

$1.48

Daily low

$1.34

Price at open

$1.41

52 Week High

$11.64

52 Week Low

$1.09

Market cap

38.5M

Dividend yield

0.00%

Volume

284,420

Avg. volume

296,789

P/E ratio

-.86

INmune Bio News